# Boncresa

NDC: 70121-2702
Generic name: denosumab-mobz
Labeler / Manufacturer: Amneal Pharmaceuticals LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Biologic License Application
Dosage form: INJECTION, SOLUTION
Routes: SUBCUTANEOUS
Marketing started: 20251223

FDA application: BLA761456

## Active ingredients

- DENOSUMAB: 60 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"70121-2702"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=70121-2702
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=29140df2-24a3-4a6f-a8e3-065521448d61